{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:55:06Z","timestamp":1791863706716,"version":"4.3.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Scientific Research on Innovative Areas","award":["26110723"],"award-info":[{"award-number":["26110723"]}]},{"name":"Grant-in-Aid for Challenging Exploratory Research","award":["26670148"],"award-info":[{"award-number":["26670148"]}]},{"name":"Grant-in-Aid for Challenging Exploratory Research","award":["15K14481"],"award-info":[{"award-number":["15K14481"]}]},{"name":"Grant-in-Aid for Scientific Research","award":["15H04700"],"award-info":[{"award-number":["15H04700"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bbagen.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T16:15:28Z","timestamp":1493482528000},"page":"2447-2454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["N -glycan and Alzheimer's disease"],"prefix":"10.1016","volume":"1861","author":[{"given":"Yasuhiko","family":"Kizuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Kitazume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2017.04.012_bb0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","article-title":"Resolving controversies on the path to Alzheimer's therapeutics","volume":"17","author":"Selkoe","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/475S2a","article-title":"Dementia: a problem for our age","volume":"475","author":"Abbott","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0020","series-title":"World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends","author":"Prince","year":"2015"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2016.07.011","article-title":"The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues","volume":"52","author":"Porteri","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1741-7015-10-127","article-title":"Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals","volume":"10","author":"Lazarczyk","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0035","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0050","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1471-4159.2010.07081.x","article-title":"alpha-Secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential","volume":"116","author":"Lichtenthaler","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1126\/science.8424174","article-title":"Release of excess amyloid beta protein from a mutant amyloid beta protein precursor","volume":"259","author":"Cai","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0070","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain Abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/77399","article-title":"Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tins.2016.01.003","article-title":"BACE1 physiological functions may limit its use as therapeutic target for Alzheimer's disease","volume":"39","author":"Barao","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","article-title":"Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects","volume":"130","author":"Vassar","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/febs.12590","article-title":"The role of protein glycosylation in Alzheimer disease","volume":"281","author":"Schedin-Weiss","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"Ohtsubo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2016.04.008","article-title":"Disease-associated glycans on cell surface proteins","volume":"51","author":"Takahashi","year":"2016","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0115","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.bbamcr.2013.04.001","article-title":"N-linked protein glycosylation in the ER","volume":"1833","author":"Aebi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0120","series-title":"Essentials of Glycobiology, Cold Spring Harbor (NY)","article-title":"N-glycans","author":"Stanley","year":"2009"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/bs.acr.2014.11.001","article-title":"Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics","volume":"126","author":"Taniguchi","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0135","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10719-008-9140-x","article-title":"Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins","volume":"25","author":"Akasaka-Manya","year":"2008","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.1995.1716","article-title":"N-linked oligosaccharide of beta-amyloid precursor protein (beta APP) of C6 glioma cells: putative regulatory role in beta APP processing","volume":"210","author":"Saito","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0145","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1074\/jbc.273.11.6277","volume":"273","author":"Tomita","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jnr.490410214","article-title":"Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine","volume":"41","author":"Griffith","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/jb\/mvw056","article-title":"Excess APP O-glycosylation by GalNAc-T6 decreases Abeta production","volume":"161","author":"Akasaka-Manya","year":"2017","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0160","doi-asserted-by":"crossref","first-page":"40097","DOI":"10.1074\/jbc.M110.144626","article-title":"Brain endothelial cells produce amyloid {beta} from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form","volume":"285","author":"Kitazume","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0165","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.carres.2009.04.031","article-title":"Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins","volume":"344","author":"Takahashi","year":"2009","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0306-4522(98)00361-3","article-title":"The role of the protein glycosylation state in the control of cellular transport of the amyloid beta precursor protein","volume":"90","author":"McFarlane","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0175","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1471-4159.2005.03595.x","article-title":"Sialylation enhances the secretion of neurotoxic amyloid-beta peptides","volume":"96","author":"Nakagawa","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BJ20150607","article-title":"Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions","volume":"473","author":"Kizuka","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0185","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1091\/mbc.E08-05-0459","article-title":"Consequences of individual N-glycan deletions and of proteasomal inhibition on secretion of active BACE","volume":"19","author":"Vanoni","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20070040","article-title":"A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1","volume":"407","author":"Costantini","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0195","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1074\/jbc.M009899200","article-title":"Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane\/cytosolic domains affect its cellular activity and amyloid-beta production","volume":"276","author":"Benjannet","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15252\/emmm.201404438","article-title":"An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease","volume":"7","author":"Kizuka","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0205","doi-asserted-by":"crossref","first-page":"18199","DOI":"10.1016\/S0021-9258(19)37172-8","article-title":"Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney","volume":"267","author":"Nishikawa","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1471-4159.2011.07623.x","article-title":"Beta-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis","volume":"120","author":"Tan","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2013.05.035","article-title":"Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway","volume":"79","author":"Das","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0220","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1042\/BCJ20160147","article-title":"Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions","volume":"473","author":"Toh","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0225","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","article-title":"Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons","volume":"31","author":"Kuhn","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0230","doi-asserted-by":"crossref","first-page":"25927","DOI":"10.1074\/jbc.M112.377465","article-title":"The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo","volume":"287","author":"Zhou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0235","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","article-title":"Control of peripheral nerve myelination by the beta-secretase BACE1","volume":"314","author":"Willem","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0240","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/nn1797","article-title":"Bace1 modulates myelination in the central and peripheral nervous system","volume":"9","author":"Hu","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/emboj.2013.146","article-title":"Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles","author":"Cheret","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0250","doi-asserted-by":"crossref","first-page":"30797","DOI":"10.1074\/jbc.M505249200","article-title":"Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice","volume":"280","author":"Dominguez","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0255","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1073\/pnas.0710373105","article-title":"Alteration of BACE1-dependent NRG1\/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice","volume":"105","author":"Savonenko","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/glycob\/7.1.45","article-title":"Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction","volume":"7","author":"Priatel","year":"1997","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0265","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1073\/pnas.241509198","article-title":"Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase","volume":"98","author":"Kitazume","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0270","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1074\/jbc.M409417200","article-title":"In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase","volume":"280","author":"Kitazume","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0275","doi-asserted-by":"crossref","first-page":"34896","DOI":"10.1074\/jbc.M704766200","article-title":"Beta-galactoside alpha2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for alpha2,6-sialylation","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0280","doi-asserted-by":"crossref","first-page":"40256","DOI":"10.1038\/srep40256","article-title":"TNF-alpha regulates the proteolytic degradation of ST6Gal-1 and endothelial cell-cell junctions through upregulating expression of BACE1","volume":"7","author":"Deng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0285","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10719-006-6671-x","article-title":"Screening a series of sialyltransferases for possible BACE1 substrates","volume":"23","author":"Kitazume","year":"2006","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0290","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35017105","article-title":"Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells","volume":"2","author":"Herreman","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/35017108","article-title":"Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1","volume":"2","author":"Zhang","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0300","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/ncb1201-1129","article-title":"Nicastrin is required for presenilin-mediated transmembrane cleavage in Drosophila","volume":"3","author":"Chung","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/35024009","article-title":"Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and betaAPP processing","volume":"407","author":"Yu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","article-title":"aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation","volume":"3","author":"Francis","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0315","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.022523499","article-title":"APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos","volume":"99","author":"Goutte","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0320","doi-asserted-by":"crossref","first-page":"39062","DOI":"10.1074\/jbc.C200469200","article-title":"PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin","volume":"277","author":"Steiner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0325","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","article-title":"A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain","volume":"398","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/387288a0","article-title":"Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm","volume":"387","author":"Wong","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0335","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","article-title":"gamma-Secretase inhibitors and modulators","volume":"1828","author":"Golde","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0340","doi-asserted-by":"crossref","first-page":"28135","DOI":"10.1074\/jbc.M110871200","article-title":"Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins","volume":"277","author":"Yang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0345","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1242\/jcs.00292","article-title":"gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation","volume":"116","author":"Herreman","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(02)02802-8","article-title":"Complex N-glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments","volume":"520","author":"Tomita","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(03)00544-5","article-title":"The over-expression of the wild type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line","volume":"346","author":"Farquhar","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0360","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","article-title":"Presenilin 1 maintains lysosomal Ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0365","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0370","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1523\/JNEUROSCI.0556-12.2012","article-title":"A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1083\/jcb.201201076","article-title":"Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells","volume":"198","author":"Coen","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0380","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.67051882.x","article-title":"Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain","volume":"67","author":"Furukawa","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0385","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1073\/pnas.95.21.12683","article-title":"Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice","volume":"95","author":"Meziane","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0390","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1523\/JNEUROSCI.5221-09.2010","article-title":"The disintegrin\/metalloproteinase ADAM10 is essential for the establishment of the brain cortex","volume":"30","author":"Jorissen","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0395","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/emboj.2010.167","article-title":"ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons","volume":"29","author":"Kuhn","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0400","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbagen.2008.03.004","article-title":"Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme","volume":"1780","author":"Escrevente","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0405","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0415","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0420","doi-asserted-by":"crossref","first-page":"28741","DOI":"10.1074\/jbc.271.46.28741","article-title":"The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine","volume":"271","author":"Arnold","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0425","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0430","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nn.4067","article-title":"Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice","volume":"18","author":"Morris","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0435","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(01)02421-8","article-title":"Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease","volume":"496","author":"Sato","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0440","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(02)02228-7","article-title":"Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease","volume":"512","author":"Liu","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0445","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm0896-871","article-title":"Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease","volume":"2","author":"Wang","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0450","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0196-9781(95)00021-B","article-title":"Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism","volume":"16","author":"Howell","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0455","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nm1206","article-title":"Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation","volume":"11","author":"Saito","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0460","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.bbagen.2012.06.017","article-title":"The human CD10 lacking an N-glycan at Asn(628) is deficient in surface expression and neutral endopeptidase activity","volume":"1820","author":"Sato","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt 2","key":"10.1016\/j.bbagen.2017.04.012_bb0465","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/bj3020451","article-title":"Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11","volume":"302","author":"Lafrance","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng718","article-title":"The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy","volume":"29","author":"Eisenberg","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0475","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-4159.2007.05208.x","article-title":"Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle","volume":"105","author":"Broccolini","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0480","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0485","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrneurol.2016.84","article-title":"Genetic variants in Alzheimer disease - molecular and brain network approaches","volume":"12","author":"Gaiteri","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0490","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0495","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1074\/jbc.R115.704981","article-title":"The triggering receptor expressed on myeloid cells 2: a molecular link of neuroinflammation and neurodegenerative diseases","volume":"291","author":"Walter","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0500","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp.74.6.825-a","article-title":"An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene","volume":"74","author":"Soragna","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0510","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0515","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12035-013-8424-8","article-title":"TREM2 in Alzheimer's disease","volume":"48","author":"Jiang","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0520","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0530","doi-asserted-by":"crossref","DOI":"10.1042\/AN20100010","article-title":"Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease","volume":"2","author":"Melchior","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0535","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","article-title":"Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease","volume":"37","author":"Jay","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0540","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0545","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0550","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","article-title":"TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques","volume":"213","author":"Wang","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0555","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0560","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E","volume":"290","author":"Bailey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0565","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tra.12264","article-title":"Disease-associated mutations of TREM2 alter the processing of N-linked oligosaccharides in the golgi apparatus","volume":"16","author":"Park","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.bbagen.2017.04.012_bb0570","first-page":"618","article-title":"The Alzheimer's disease-associated R47H variant of TREM2 has an altered glycosylation pattern and protein stability","volume":"10","author":"Park","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbagen.2017.04.012_bb0575","doi-asserted-by":"crossref","first-page":"20664","DOI":"10.1074\/jbc.M109.055608","article-title":"The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein","volume":"285","author":"Ullrich","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651730137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651730137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T21:25:23Z","timestamp":1719177923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651730137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":115,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S030441651730137X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2017.04.012","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-glycan and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}